Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 13139 | 794 | 29.3 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1822 | 5688 | POMPE DISEASE//GLYCOGEN STORAGE DISEASE TYPE II//GLYCOGEN STORAGE DISEASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LAFORA DISEASE | Author keyword | 160 | 88% | 10% | 77 |
| 2 | POLYGLUCOSAN BODIES | Author keyword | 94 | 97% | 4% | 28 |
| 3 | UNVERRICHT LUNDBORG DISEASE | Author keyword | 50 | 76% | 4% | 35 |
| 4 | EPM2A | Author keyword | 48 | 100% | 2% | 17 |
| 5 | ADULT POLYGLUCOSAN BODY DISEASE | Author keyword | 41 | 90% | 2% | 18 |
| 6 | LAFORIN | Author keyword | 39 | 73% | 4% | 30 |
| 7 | PROGRESSIVE MYOCLONUS EPILEPSY | Author keyword | 36 | 53% | 6% | 47 |
| 8 | LAFORA BODIES | Author keyword | 35 | 86% | 2% | 18 |
| 9 | LAFORAS DISEASE | Author keyword | 24 | 91% | 1% | 10 |
| 10 | POLYGLUCOSAN BODY | Author keyword | 23 | 86% | 2% | 12 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LAFORA DISEASE | 160 | 88% | 10% | 77 | Search LAFORA+DISEASE | Search LAFORA+DISEASE |
| 2 | POLYGLUCOSAN BODIES | 94 | 97% | 4% | 28 | Search POLYGLUCOSAN+BODIES | Search POLYGLUCOSAN+BODIES |
| 3 | UNVERRICHT LUNDBORG DISEASE | 50 | 76% | 4% | 35 | Search UNVERRICHT+LUNDBORG+DISEASE | Search UNVERRICHT+LUNDBORG+DISEASE |
| 4 | EPM2A | 48 | 100% | 2% | 17 | Search EPM2A | Search EPM2A |
| 5 | ADULT POLYGLUCOSAN BODY DISEASE | 41 | 90% | 2% | 18 | Search ADULT+POLYGLUCOSAN+BODY+DISEASE | Search ADULT+POLYGLUCOSAN+BODY+DISEASE |
| 6 | LAFORIN | 39 | 73% | 4% | 30 | Search LAFORIN | Search LAFORIN |
| 7 | PROGRESSIVE MYOCLONUS EPILEPSY | 36 | 53% | 6% | 47 | Search PROGRESSIVE+MYOCLONUS+EPILEPSY | Search PROGRESSIVE+MYOCLONUS+EPILEPSY |
| 8 | LAFORA BODIES | 35 | 86% | 2% | 18 | Search LAFORA+BODIES | Search LAFORA+BODIES |
| 9 | LAFORAS DISEASE | 24 | 91% | 1% | 10 | Search LAFORAS+DISEASE | Search LAFORAS+DISEASE |
| 10 | POLYGLUCOSAN BODY | 23 | 86% | 2% | 12 | Search POLYGLUCOSAN+BODY | Search POLYGLUCOSAN+BODY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PROGRESSIVE MYOCLONUS EPILEPSY | 132 | 46% | 27% | 214 |
| 2 | EPM2A GENE | 86 | 96% | 3% | 26 |
| 3 | BRANCHING ENZYME GENE | 55 | 92% | 3% | 22 |
| 4 | IV GLYCOGENOSIS | 52 | 87% | 3% | 26 |
| 5 | POLYGLUCOSAN BODIES | 50 | 88% | 3% | 23 |
| 6 | EPM1 | 41 | 65% | 5% | 40 |
| 7 | BALTIC MYOCLONUS | 41 | 100% | 2% | 15 |
| 8 | POLYGLUCOSAN BODY DISEASE | 37 | 59% | 5% | 41 |
| 9 | MALIN | 33 | 83% | 2% | 19 |
| 10 | LAFORA DISEASE | 30 | 56% | 5% | 37 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii | 2013 | 11 | 82 | 71% |
| Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy | 2006 | 69 | 31 | 94% |
| Corpora-amylacea and the family of polyglucosan diseases | 1999 | 124 | 121 | 64% |
| Clinical picture of EPM1-Unverricht-Lundborg disease | 2008 | 50 | 43 | 81% |
| Lafora's disease: Towards a clinical, pathologic, and molecular synthesis | 2001 | 73 | 39 | 67% |
| Advances in Lafora progressive myoclonus epilepsy | 2007 | 38 | 25 | 84% |
| Laforin Prevents Stress-Induced Polyglucosan Body Formation and Lafora Disease Progression in Neurons | 2013 | 3 | 39 | 72% |
| Deciphering the role of malin in the lafora progressive myoclonus epilepsy | 2012 | 4 | 50 | 88% |
| Genetic diagnosis in Lafora disease - Genotype-phenotype correlations and diagnostic pitfalls | 2007 | 15 | 25 | 100% |
| Lafora disease: insights into neurodegeneration from plant metabolism | 2009 | 27 | 83 | 49% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DIAG CARE EPILEPSY | 6 | 80% | 0.5% | 4 |
| 2 | EPILEPSY GENET GENOM S | 5 | 37% | 1.3% | 10 |
| 3 | HOSP BELLE IDEE | 2 | 67% | 0.3% | 2 |
| 4 | UO NEUROMUSCULAR NEURODEGENERAT DIS | 2 | 67% | 0.3% | 2 |
| 5 | W LOS ANGELES DVA MED | 2 | 67% | 0.3% | 2 |
| 6 | CHILD EEG UNIT | 1 | 50% | 0.3% | 2 |
| 7 | EPILEPSY EXCELLENCE NEUROL SERV | 1 | 50% | 0.3% | 2 |
| 8 | NEUROLCOMPREHENS EPILEPSY PROGRAM | 1 | 50% | 0.3% | 2 |
| 9 | NEUROPHYSIOPATHOL EPILEPSY | 1 | 33% | 0.4% | 3 |
| 10 | W LOS ANGELES MED | 1 | 22% | 0.5% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000137513 | PALATAL MYOCLONUS//SPINAL MYOCLONUS//PROPRIOSPINAL MYOCLONUS |
| 2 | 0.0000125430 | GLYCOGENIN//MACROGLYCOGEN//PROGLYCOGEN |
| 3 | 0.0000082204 | CYSTATIN//HUMAN CYSTATIN C//CYSTEINE PROTEINASE INHIBITOR |
| 4 | 0.0000074235 | EQUINE MOTOR NEURON DISEASE//POLYSACCHARIDE STORAGE MYOPATHY//ATYPICAL MYOPATHY |
| 5 | 0.0000064783 | NEURONAL INTRANUCLEAR INCLUSION DISEASE//INTRANUCLEAR INCLUSION BODY DISEASE//NEURONAL INTRANUCLEAR HYALINE INCLUSION DISEASE |
| 6 | 0.0000064369 | AUDITORY DISTURBANCE//PERIPHERAL NEUROMUSCULAR FUNCTION//ACUTE FORM |
| 7 | 0.0000061754 | BATTEN DISEASE//NEURONAL CEROID LIPOFUSCINOSIS//NEURONAL CEROID LIPOFUSCINOSES |
| 8 | 0.0000060831 | ARHI//NEURONATIN//APLASIA RAS HOMOLOG MEMBER I |
| 9 | 0.0000056373 | MCARDLES DISEASE//MCARDLE DISEASE//MYOPHOSPHORYLASE |
| 10 | 0.0000052655 | TNFAIP1//KCTD7//KCTD10 |